Farmacogenómica del Cáncer ; Pharmacogenomic of cancer
Gedelcan
Instituto de Investigaciones Biomédicas Alberto Sols
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigaciones Biomédicas Alberto Sols (7)
2024
-
Protein kinase D activity is a risk biomarker in prostate cancer that drives cell invasion by a Snail/ERK dependent mechanism
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 1
2020
-
Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice
Molecular Metabolism, Vol. 35
2014
-
Thyroid Hormone Receptors and their Role in Cell Proliferation and Cancer
Cellular Endocrinology in Health and Disease (Elsevier Inc.), pp. 1-17
2013
-
Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1
Toxicology and Applied Pharmacology, Vol. 272, Núm. 3, pp. 568-578
2011
-
The growing role of gene methylation on endocrine function
Journal of Molecular Endocrinology, Vol. 47, Núm. 2
-
The thyroid hormone receptors as tumor suppressors
Hormone Molecular Biology and Clinical Investigation, Vol. 5, Núm. 2, pp. 79-89
2008
-
Histone deacetylase inhibitors: Mechanism of action and therapeutic use in cancer
Clinical and Translational Oncology, Vol. 10, Núm. 7, pp. 395-398